3 recruiting, 1 completed, 1 suspended, 1 withdrawn. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 3, Completed 1, Suspended 1, Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Lassa Fever: new trials by email Literature Review of Lassa Fever trials Research Report on Lassa Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ARN-75039 Lassa Fever Treatment in West Africa ARN-75039 high, Intravenous ribavirin, ARN-75039 low - Lassa Fever | Phase 2 | Suspended | Arisan Therapeutics, Inc. | 135 | 2026-02-14 | 2026-07-06 |
| ISTH/ANRS 0409s INTEGRATE Lassa Fever Study Favipiravir, Ribavirin, Dexamethasone - Lassa Fever | Phase 2 / Phase 3 | Recruiting | Irrua Specialist Teaching Hospital | 1755 | 2025-05-02 | 2026-02-04 |
| A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa Day 1 Dose (2×106 pfu), Day 1 Dose (1×107 pfu), Placebo - Lassa Fever | Phase 2 | Recruiting | International AIDS Vaccine Initiative | 530 | 2024-03-06 | 2026-10-23 |
| LAssa Fever Adjunct Treatment With DEXamethasone Dexamethasone, Ribavirin - Lassa Fever | Phase 2 | Recruiting | Bernhard Nocht Institute for Tropical Medicine | 42 | 2024-02-05 | 2025-02-06 |
| Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever Ribavirin iv, Favipiravir - Lassa Fever | Phase 2 | Completed | Bernhard Nocht Institute for Tropical Medicine | 40 | 2021-07-30 | 2023-02-08 |
| Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities Ribavirin (Virazole) Injection - Crimean-Congo Hemorrhagic Fever, Lassa Fever | Phase 2 | Withdrawn | U.S. Army Medical Research and Development Command | 2009-09-01 | 2020-01-02 |
Hemorrhagic Fevers, Viral (4) · Communicable Diseases, Emerging (2) · Hemorrhagic Fever, Crimean (1) · Neglected Diseases (1)
Arenaviridae Infections (6) · Infections (6) · RNA Virus Infections (6) · Virus Diseases (6) · Communicable Diseases (2) · Disease Attributes (2) · Hemorrhagic Fevers, Viral (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arbovirus Infections (1) · Bunyaviridae Infections (1) · Tick-Borne Diseases (1) · Vector Borne Diseases (1)
Ribavirin (3) · Dexamethasone (2) · favipiravir (2) · Injections (1) · Standard of Care (1)
Bernhard Nocht Institute for Tropical Medicine (2) · Arisan Therapeutics, Inc. (1) · International AIDS Vaccine Initiative (1) · Irrua Specialist Teaching Hospital (1) · U.S. Army Medical Research and Development Command (1)
Nigeria (5) · Liberia (2) · Germany (1) · Ghana (1) · United States (1)
Elizabeth Rini, MD (1) · Ken McCormack, PhD (1) · Oluwafemi Ayodeji, Dr (1) · Peter Akhideno, Dr (1) · Sylvanus Okogbenin, Prof (1)
2023 (1)